Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020

MLA

Kristine Macartney, et al. “Seroprevalence of SARS‐CoV‐2‐specific Antibodies in Sydney after the First Epidemic Wave of 2020.” The Medical Journal of Australia, vol. 214, no. 4, Feb. 2021, pp. 179–85. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e871792a97f719ab2fd6c0d0f70ce36f&authtype=sso&custid=ns315887.

APA

Kristine Macartney, Dorothy A Machalek, Hannah Shilling, Helen E. Quinn, Iain B Gosbell, Linda Hueston, Alexandra Hendry, John M. Kaldor, David O Irving, Dominic E. Dwyer, Marnie Downes, Kaitlyn Vette, Frank Beard, Heather F. Gidding, Matthew V. N. O’Sullivan, John B. Carlin, & Rena Hirani. (2021). Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020. The Medical Journal of Australia, 214(4), 179–185.

Chicago

Kristine Macartney, Dorothy A Machalek, Hannah Shilling, Helen E. Quinn, Iain B Gosbell, Linda Hueston, Alexandra Hendry, et al. 2021. “Seroprevalence of SARS‐CoV‐2‐specific Antibodies in Sydney after the First Epidemic Wave of 2020.” The Medical Journal of Australia 214 (4): 179–85. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e871792a97f719ab2fd6c0d0f70ce36f&authtype=sso&custid=ns315887.